CME chief executive says company plans to sue CFTC after perpetual futures approval

CME Group Chief Executive Terrence Duffy announced plans to sue the Commodity Futures Trading Commission (CFTC) on March 18, 2024, following the regulator's approval of Kalshi's perpetual futures product. Duffy stated that Kalshi's offering does not meet the Dodd-Frank Act's definition of a "swap" and therefore should not have received CFTC approval. He argued that this decision creates an uneven playing field, allowing a regulated exchange to list products that CME Group, as a designated contract market, is restricted from offering. Duffy emphasized that CME Group has been compliant with regulations for 150 years and that the CFTC's decision undermines the integrity of the derivatives market. The CME Group's legal challenge aims to ensure fair competition and adherence to existing financial regulations. This action highlights ongoing tensions between established exchanges and newer platforms seeking to introduce innovative financial products.